⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246512 | 0.79 | — | — | |
| SCHEMBL9247701 | 0.74 | — | — | |
| SCHEMBL105791 | 0.74 | — | — | |
| SCHEMBL8617092 | 0.74 | — | — | |
| SCHEMBL104496 | 0.74 | — | — | |
| SCHEMBL102953 | 0.69 | — | — | |
| SCHEMBL296540 | 0.65 | — | — | |
| SCHEMBL27001615 | 0.58 | — | — | |
| SCHEMBL3630272 | 0.54 | — | — | |
| SCHEMBL7719297 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 905 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113831326-A | Condensed heterocyclic derivative and application thereof in medicine | 四川海思科制药有限公司 | 2021-12-24 | — | — | CN | claimed |
| CN-112375074-A | Substituted pyrimidine compound as phosphatidylinositol 3-kinase delta inhibitor and application thereof | 南京圣和药业股份有限公司 | 2021-02-19 | — | — | CN | claimed |
| US-20210002230-A1 | OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE | Stingthera, Inc. | 2021-01-07 | — | — | US | claimed |
| EP-3713920-A1 | OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE | Silicon Swat, Inc. (US) | 2020-09-30 | — | — | EP | claimed |
| CN-111630036-A | Oxoacridinylacetic acid derivatives and methods of use thereof | 西利康斯瓦特股份有限公司 | 2020-09-04 | — | — | CN | claimed |
| US-20190161449-A1 | OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE | SILICON SWAT, INC. | 2019-05-30 | — | — | US | claimed |
| US-9470691-B2 | Application of reduced dyes in imaging | LI-COR, INC. (US) | 2016-10-18 | — | — | US | claimed |
| US-8580795-B2 | Heterocyclic compounds as phosphodiesterase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-11-12 | — | — | US | claimed |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2011-11-03 | — | — | US | claimed |
| EP-2379538-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | Orchid Research Laboratories Limited (IN) | 2011-10-26 | — | — | EP | claimed |
| WO-2010084402-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2010-07-29 | — | — | WO | claimed |
| CN-118290357-A | Heterocyclic compounds useful in the treatment of disease | 艾匹根生物技术有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118290298-A | Benzoyl hydrazine compound and synthetic method and application thereof | 南京农业大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-116143757-B | Multifunctional compound, composition and application of degradable BTK kinase | 杭州和正医药有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240218010-A1 | Methods of Producing Sulfated Oligosaccharide Derivatives and Intermediates Thereof | PROGEN PG500 SERIES PTY LTD (AU) | 2024-07-04 | — | — | US | disclosed |
| US-5003070-A | Antilipemic agents; arteriosclerosis; antibiotics | CIBA-GEIGY CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| US-4966973-A | LIPOXYGENASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-10-30 | — | — | US | disclosed |
| EP-0345592-A1 | Novel 2-substituted coumaran derivatives | Takeda Chemical Industries, Ltd. (JP) | 1989-12-13 | — | — | EP | disclosed |
| US-4879389-A | HYDROGENATION CATALYSTS | ACHIWA KAZUO (JP) | 1989-11-07 | — | — | US | disclosed |
| EP-0251164-A2 | New chiral phosphinopyrrolidine compounds and their use for asymetric synthesis of optically active compounds | Achiwa, Kazuo (JP) | 1988-01-07 | — | — | EP | disclosed |